PROGRESSION OF DIABETIC RETINOPATHY AND BLOOD FIBRINOGEN IN PATIENTS WITH TYPE 2 DIABETES (35-39)

Список литературы: 1. Kyryliuk ML, Kostiev FI, Pidaiev AV, Shataliuk SS. [Biometric and biochemical parameters of metabolic syndrome and risk of its occurrence in patients with benign prostatic hyperplasia]. Klinichna endokrynolohiia i endokrynna khyrurhiia. 2012;(3):5358. [Ukrainian]. 2. Kyryliuk ML, Malachkova NV, Komarovskaya IV. [Diabetic retinopathy and sex hormone-binding globulin: hypothesis or the real relationship?] Klinichna endokrynolohiia i endokrynna khyrurhiia. 2017;(3):65-72. [Russian]. 3. Serdyuk VN, Ishсhenko VA. [Morphometrial and biochemical clusters of metabolic syndrome in patients with type 2 diabetes mellitus at different stages of diabetic retinopathy]. Mizhnarodnyi endokrynolohichnyi zhurnal. 2016;(7):69-74. [Russian]. doi: http://dx.doi.org/10.22141/2224- 0721.7.79.2016.86421 4. Azad N, Agrawal L, Emanuele NV, Klein R, Bahn GD, McCarren M, Reaven P, Hayward R, Duckworth W; VADT Study Group. Association of PAI-1 and fibrinogen with diabetic retinopathy in the Veterans Affairs Diabetes Trial (VADT). Diabetes Care. 2014 Feb;37(2):501-506. 5. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486-2497. 6. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F; American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and Management of the Metabolic Syndrome. Circulation. 2005;112(17):2735-2752. http://dx.doi. org/10.1161/CIRCULATIONAHA.105.169404. 7. Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2015;38(1):140-149. doi: 10.2337/dc14-2441. 8. Mahendra JV, et al. Plasma Fibrinogen in Type 2 Diabetic Patients with Metabolic Syndrome and its Relation with Ischemic Heart Disease (IHD) and Retinopathy. J Clin Diagn Res. 2015 Jan;9(1):BC18- BC21. doi: 10.7860/JCDR/2015/10712.5449. 9. Reaven GM. Banting Lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988;37(12):1595-1607.